prasterone


( Last Updated : September 2, 2021)
Generic Name:
prasterone
Project Status:
Pending
Therapeutic Area:
Postmenopausal vulvovaginal atrophy
Manufacturer:
Lupin Pharma Canada Ltd.
Call for patient/clinician input open:
Brand Name:
Intrarosa
Project Line:
Reimbursement Review
Project Number:
SR0707-000
Call for patient/clinician input closed:

Details

Manufacturer Requested Reimbursement Criteria1:
​Intrarosa (prasterone vaginal ovules) is indicated for treatment of postmenopausal vulvovaginal atrophy.
Submission Type:
Initial
Fee Schedule:
Pending
Indications:
​Intrarosa (prasterone vaginal ovules) is indicated for treatment of postmenopausal vulvovaginal atrophy.
Anticipated Date:
  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.